Cancer Therapy
Lapatinib shows antitumor activity in herceptin-resistant breast cancer patients
Published in Women's Health Weekly, July 8th, 2004
Objective response or stable disease (lasting 8-16 weeks) were reported in 46% of women (scheduled interim analysis, first 41 patients on study) with heavily pretreated advanced metastatic breast cancer whose disease had previously progressed on trastuzumab (Herceptin) containing regimens (including chemotherapy, hormones, etc.), according to interim results.
The study was designed to determine tumor response rate and tolerability in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Assisted Reproduction
ART can't compensate for waiting too long to start a family - Breast Cancer
Study offers new target to stop cancer growth - Endocrinology
Animal study reveals negative adrenocortical effects of long-term estrogen - Hormone Replacement Therapy
New study finds estrogen use doesn't reduce dementia risk in older women - Polycystic Ovary Syndrome
Study finds rosiglitazone a "promising, well-tolerated" treatment for PCOS - Adrenal Incidentaloma
Female AI patients with hypercortisolism are at risk for low spinal BMD - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
